Andrea Ghezzi

Modena, 41125, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Correction: Verde et al. Molecular Mechanisms of Protein Aggregation in ALS-FTD: Focus on TDP-43 and Cellular Protective Responses. Cells 2025, 14, 680.

Correction: Verde et al. Molecular Mechanisms of Protein Aggregation in ALS-FTD: Focus on TDP-43 and Cellular Protective Responses. Cells 2025, 14, 680.

Journal: Cells
Published: March 27, 2026

Circulating Serum Cell-Free Mitochondrial DNA in Amyotrophic Lateral Sclerosis.

Circulating Serum Cell-Free Mitochondrial DNA in Amyotrophic Lateral Sclerosis.

Journal: Cells
Published: July 18, 2025

Exploring the Role of Diabetes in ALS: A Population-Based Cohort Study.

Exploring the Role of Diabetes in ALS: A Population-Based Cohort Study.

Journal: Life (Basel, Switzerland)
Published: May 15, 2025

Molecular Mechanisms of Protein Aggregation in ALS-FTD: Focus on TDP-43 and Cellular Protective Responses.

Molecular Mechanisms of Protein Aggregation in ALS-FTD: Focus on TDP-43 and Cellular Protective Responses.

Journal: Cells
Published: March 25, 2025

Phenotypical Characterization of C9ALS Patients from the Emilia Romagna Registry of ALS: A Retrospective Case-Control Study.

Phenotypical Characterization of C9ALS Patients from the Emilia Romagna Registry of ALS: A Retrospective Case-Control Study.

Journal: Genes
Published: January 29, 2025

Predictors from systemic and neuro-inflammation in amyotrophic lateral sclerosis: A monocentric experience.

Predictors from systemic and neuro-inflammation in amyotrophic lateral sclerosis: A monocentric experience.

Journal: Journal of neuroimmunology
Published: December 27, 2024

Multifaceted superoxide dismutase 1 expression in amyotrophic lateral sclerosis patients: a rare occurrence?

Multifaceted superoxide dismutase 1 expression in amyotrophic lateral sclerosis patients: a rare occurrence?

Journal: Neural regeneration research
Published: November 20, 2023

Correction to: Retrospective observational study on the use of acetyl-L-carnitine in ALS.

Correction to: Retrospective observational study on the use of acetyl-L-carnitine in ALS.

Journal: Journal of neurology
Published: September 08, 2023

Effect of tauroursodeoxycholic acid on survival and safety in amyotrophic lateral sclerosis: a retrospective population-based cohort study.

Effect of tauroursodeoxycholic acid on survival and safety in amyotrophic lateral sclerosis: a retrospective population-based cohort study.

Journal: EClinicalMedicine
Published: June 29, 2023

Predictors for progression in amyotrophic lateral sclerosis associated to SOD1 mutation: insight from two population-based registries.

Predictors for progression in amyotrophic lateral sclerosis associated to SOD1 mutation: insight from two population-based registries.

Journal: Journal of neurology
Published: June 07, 2023

SerpinA1 levels in amyotrophic lateral sclerosis patients: An exploratory study.

SerpinA1 levels in amyotrophic lateral sclerosis patients: An exploratory study.

Journal: European journal of neurology
Published: May 17, 2023

Retrospective observational study on the use of acetyl-L-carnitine in ALS.

Retrospective observational study on the use of acetyl-L-carnitine in ALS.

Journal: Journal of neurology
Published: May 04, 2023
Showing 1-12 of 15

Last Updated: 09/26/2026